查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1518350

癌症資訊系統市場：依產品、應用和最終用戶劃分 - 2030 年全球預測

Oncology Information Systems Market By Offering (Software Services) Application (Medical, Surgical, Radiology Oncology) End User (Hospital, Diagnostic Imaging Center, Cancer Care Center) - Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 180 Pages | 商品交期: 5-7個工作天內

價格

癌症資訊系統市場預計到 2030 年將達到 44.5 億美元，2023 年至 2030 年複合年增長率為 7.4%。

經過廣泛的二次和初步研究以及對市場情景的詳細分析，本報告對關鍵行業驅動因素、限制因素和市場驅動因素/課題進行了分析。

該市場的成長是由癌症盛行率不斷上升、癌症治療數位化程度不斷提高、降低癌症治療成本的需求不斷增加、電子健康記錄(EHR) 的採用不斷增加所推動的，這是由患者需求的不斷增長所推動的資訊和數據管理。

然而，癌症資訊系統的高成本以及對資料安全和隱私的擔憂正在限制該市場的成長。此外，精準醫學融入癌症治療及其在新興國家日益增長的潛力預計將為該市場的參與者提供重大的成長機會。

然而，採用和實施癌症資訊系統的障礙以及使用癌症資訊系統的培訓和教育的額外要求是限制市場成長的主要課題。

目錄

第一章簡介

第二章研究方法

第 3 章執行概述

第 4 章市場洞察

  • 市場概覽
  • 促進因素
    • 癌症盛行率不斷上升
    • 癌症治療數位化的進展
    • 降低癌症醫療費用的需求日益增加
    • 擴大採用電子健康記錄 (EHR)
    • 對簡化病患資訊和資料管理的需求不斷增加
  • 抑制因素
    • 癌症資訊系統成本高昂
    • 資料安全與隱私問題
  • 機會
    • 精準醫學在癌症治療的整合
    • 新興國家的機遇
  • 作業
    • 採用和實施的障礙
    • 使用癌症資訊系統的額外培訓和教育要求
  • 價格分析
  • 監理分析
  • 個案研究
  • 產業與科技趨勢

第五章全球癌症資訊系統市場：依產品評估

  • 摘要
  • 軟體
    • 病患資訊系統
    • 治療計畫系統
  • 服務

第六章全球癌症資訊系統市場：應用評估

  • 摘要
  • 放射癌
  • 醫學癌症
  • 手術癌症

第七章癌症資訊系統的全球市場：最終用戶的評估

  • 摘要
  • 醫院
  • 影像診斷中心
  • 癌症治療中心
  • 其他

第 8 章癌症資訊系統市場：區域評估

  • 摘要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太地區其他地區
  • 拉丁美洲
  • 中東/非洲

第9章競爭分析

  • 摘要
  • 主要成長策略
  • 供應商基準測試
  • 競爭對手儀表板
    • 行業領導者
    • 市場差異化因素
    • 領先企業
    • 新興公司
  • 市佔率分析（2022 年）

第 10 章公司簡介（公司概況、財務概況、產品組合、策略發展）

  • Accuray Incorporated
  • Brainlab AG
  • DOSIsoft SA
  • Elekta AB
  • Koninklijke Philips N.V.
  • MIM Software Inc.
  • Oracle Corporation
  • Prowess Inc.
  • RaySearch Laboratories
  • Siemens Healthcare GmbH
  • ViewRay Inc.
  • McKesson Corporation
  • Altai, Inc.

（註：報告中將包含5家主要公司的SWOT分析。）

第11章附錄

Product Code: MRHC - 104908

Oncology Information Systems Market Size, Share, Forecast, & Trends Analysis by Offering (Software {Patient Information, Treatment Planning}, Services), Application (Surgical, Radiology Oncology), End User (Hospital, Cancer Care) - Global Forecast to 2030

The oncology information systems market is projected to reach $4.45 billion by 2030 at a CAGR of 7.4% from 2023 to 2030.

Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.

The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, the growing need to reduce oncology care costs, the increasing adoption of Electronic Health Records (EHR), and the growing demand for streamlined patient information and data management.

However, the high cost of oncology information systems and data security and privacy concerns are restraining the growth of this market. In addition, the integration of precision medicine into cancer treatment and its growing potential in emerging countries are expected to generate significant growth opportunities for the players in this market.

However, barriers to the adoption and implementation of oncology information systems and additional requirements for training and education for using oncology information systems are major challenges limiting the market's growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the oncology information systems market are Accuray Incorporated (U.S.), Brainlab AG (Germany), DOSIsoft SA (France), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), Oracle Corporation (U.S.), Prowess Inc. (U.S.), RaySearch Laboratories (Sweden), Siemens Healthcare GmbH (Germany), McKesson Corporation (U.S.), Altai, Inc (Turkey), and ViewRay Inc. (U.S.).

Based on offering the oncology information systems market is segmented into software and services. In 2023, the software segment is expected to account for the larger share of the oncology information systems market. The large share of this segment is attributed to the increased need to streamline patient data, the high prevalence of cancer, and the benefits of advanced features of oncology information systems such as management of patient treatment schedules, treatment plans, treatment delivery, and treatment summaries.

Based on application, the oncology information systems market is segmented into medical oncology, radiation oncology, and surgical oncology. In 2023, the medical oncology segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to the large number of patients receiving medical oncology treatments such as chemotherapy, immunotherapy, hormone therapy, and targeted therapy.

Based on end user, the oncology information systems market is segmented into hospitals, diagnostic imaging centers, cancer care centers, and other end users. In 2023, the hospitals segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to high healthcare expenditure, increased capability of hospitals to purchase and implement oncology information systems, and increased number of cancer patients relying on hospitals for treatment.

An in-depth analysis of the geographical scenario in the oncology information systems market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the oncology information systems market. North America's major market share is primarily attributed to the robust healthcare infrastructure, high healthcare expenditure, large patient population, high adoption of precision medicine, and the presence of key market players in the region.

Scope of the Report:

Oncology Information Systems Market Assessment-by Offering

  • Software
    • Patient Information Systems
    • Treatment Planning Systems
  • Services

Oncology Information Systems Market Assessment-by Application

  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology

Oncology Information Systems Market Assessment-by End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Cancer Care Centers
  • Other End Users

Note: Other end users primarily include research institutes and government institutions.

Oncology Information Systems Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency and Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for this Study

3. Executive Summary

4. Market Insights

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Prevalence of Cancer
    • 4.2.2. Rising Digitalization in Cancer Treatment
    • 4.2.3. Rising Need to Reduce Oncology Care Costs
    • 4.2.4. Increasing Adoption of Electronic Health Records (EHRs)
    • 4.2.5. Increased Demand for Streamlined Patient Information and Data Management
  • 4.3. Restraints
    • 4.3.1. High Cost of Oncology Information Systems
    • 4.3.2. Data Security and Privacy Concerns
  • 4.4. Opportunities
    • 4.4.1. Integration of Precision Medicine for Cancer Treatment
    • 4.4.2 Potential in Emerging Countries
  • 4.5. Challenges
    • 4.5.1. Barriers to Adoption and Implementation
    • 4.5.2. Additional Requirement for Training and Education for Using Oncology Information Systems
  • 4.6. Pricing Analysis
  • 4.7. Regulatory Analysis
  • 4.8. Case Studies
  • 4.9. Industry & Technology Trends

5. Global Oncology Information Systems Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Software
    • 5.2.1. Patient Information Systems
    • 5.2.2. Treatment Planning Systems
  • 5.3. Services

6. Global Oncology Information Systems Market Assessment-by Application

  • 6.1. Overview
  • 6.2. Radiation Oncology
  • 6.3. Medical Oncology
  • 6.4. Surgical Oncology

7. Global Oncology Information Systems Market Assessment-by End User

  • 7.1. Overview
  • 7.2. Hospitals
  • 7.3. Diagnostic Imaging Centers
  • 7.4. Cancer Care Centers
  • 7.5. Other End Users

8. Oncology Information Systems Market Assessment-by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. U.K.
    • 8.3.3. France
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Rest of Asia-Pacific
  • 8.5. Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Vendor Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Share Analysis (2022)

10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 10.1. Accuray Incorporated
  • 10.2. Brainlab AG
  • 10.3. DOSIsoft SA
  • 10.4. Elekta AB
  • 10.5. Koninklijke Philips N.V.
  • 10.6. MIM Software Inc.
  • 10.7. Oracle Corporation
  • 10.8. Prowess Inc.
  • 10.9. RaySearch Laboratories
  • 10.10. Siemens Healthcare GmbH
  • 10.11. ViewRay Inc.
  • 10.12. McKesson Corporation
  • 10.13. Altai, Inc.

(Note: SWOT Analysis Of The Top 5 Players Will Be Provided In The Report)

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports

LIST OF TABLES

  • Table 1 Global Oncology Information Systems Market Drivers: Impact Analysis (2024-2030)
  • Table 2 Global Oncology Information Systems Market Restraints: Impact Analysis (2024-2030)
  • Table 3 Global Oncology Information Systems Market Opportunities: Impact Analysis (2024-2030)
  • Table 4 Global Oncology Information Systems Market Challenges: Impact Analysis (2024-2030)
  • Table 5 Global Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 6 Global Oncology Information Systems Software Market, by Country/Region, 2021-2030 (USD Million)
  • Table 7 Global Oncology Information Systems Software Market, by Type, 2021-2030 (USD Million)
  • Table 8 Global Oncology Information Systems Services Market, by Country/Region, 2021-2030 (USD Million)
  • Table 9 Global Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 10 Global Oncology Information Systems Market for Medical Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 11 Global Oncology Information Systems Market for Radiation Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Global Oncology Information Systems Market for Surgical Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 13 Global Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 14 Global Oncology Information Systems Market for Hospitals, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global Oncology Information Systems Market for Diagnostic Imaging Centers, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Global Oncology Information Systems Market for Cancer Care Centers, by Country/Region, 2021-2030 (USD Million)
  • Table 17 Global Oncology Information Systems Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global Oncology Information Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 19 North America: Oncology Information Systems Market, by Country, 2021-2030 (USD Million)
  • Table 20 North America: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 21 North America: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 22 North America: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 23 North America: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 24 U.S.: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 25 U.S.: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 26 U.S.: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 27 U.S.: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 28 Canada: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 29 Canada: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 30 Canada: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 31 Canada: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 32 Europe: Oncology Information Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 33 Europe: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 34 Europe: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 35 Europe: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 36 Europe: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 37 Germany: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 38 Germany: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 39 Germany: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 40 Germany: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 41 U.K.: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 42 U.K.: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 43 U.K.: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 44 U.K.: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 45 France: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 46 France: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 47 France: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 48 France: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 49 Spain: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 50 Spain: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 51 Spain: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 52 Spain: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 53 Italy: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 54 Italy: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 55 Italy: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 56 Italy: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 57 Rest of Europe: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 58 Rest of Europe: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 59 Rest of Europe: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 60 Rest of Europe: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 61 Asia-Pacific: Oncology Information Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 62 Asia-Pacific: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 63 Asia-Pacific: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 64 Asia-Pacific: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 65 Asia-Pacific: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 66 China: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 67 China: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 68 China: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 69 China: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 70 Japan: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 71 Japan: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 72 Japan: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 73 Japan: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 74 India: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 75 India: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 76 India: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 77 India: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 78 Rest of Asia-Pacific: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 79 Rest of Asia-Pacific: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 80 Rest of Asia-Pacific: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 81 Rest of Asia-Pacific: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 82 Latin America: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 83 Latin America: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 84 Latin America: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 85 Latin America: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 86 Middle East & Africa: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 87 Middle East & Africa: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 88 Middle East & Africa: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 89 Middle East & Africa: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 90 Recent Developments, by Company (2020-2024)

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for this Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Oncology Information Systems Market, by Offering, 2024 Vs. 2030 (USD Million)
  • Figure 8 Global Oncology Information Systems Market, by Application, 2024 Vs. 2030 (USD Million)
  • Figure 9 Global Oncology Information Systems Market, by End User, 2024 Vs. 2030 (USD Million)
  • Figure 10 Global Oncology Information Systems Market, by Geography
  • Figure 11 Market Dynamics: Oncology Information Systems Market
  • Figure 12 Global Oncology Information Systems Market, by Offering, 2024 Vs. 2030 (USD Million)
  • Figure 13 Global Oncology Information Systems Market, by Application, 2024 Vs. 2030 (USD Million)
  • Figure 14 Global Oncology Information Systems Market, by End User, 2024 Vs. 2030 (USD Million)
  • Figure 15 Global Oncology Information Systems Market, by Geography, 2024 Vs. 2030 (USD Million)
  • Figure 16 North America: Oncology Information Systems Market Snapshot
  • Figure 17 Europe: Oncology Information Systems Market Snapshot
  • Figure 18 Asia-Pacific: Oncology Information Systems Market Snapshot
  • Figure 19 Key Growth Strategies Adopted by Leading Players (2020-2024)
  • Figure 20 Global Oncology Information Systems Market: Vendor Benchmarking Based on Application
  • Figure 21 Global Oncology Information Systems Market: Vendor Benchmarking Based on Geography
  • Figure 22 Global Oncology Information Systems Market: Competitive Dashboard
  • Figure 23 Market Share Analysis: Oncology Information Systems Market (2022)
  • Figure 24 Accuray Incorporated: Financial Overview (2022)
  • Figure 25 Brainlab AG: Financial Overview (2022)
  • Figure 26 Koninklijke Philips N.V.: Financial Overview (2022)
  • Figure 27 Elekta AB: Financial Overview (2022)
  • Figure 28 Oracle Corporation: Financial Overview (2022)
  • Figure 29 RaySearch Laboratories: Financial Overview (2022)
  • Figure 30 Siemens Healthcare GmbH: Financial Overview (2022)
  • Figure 31 McKesson Corporation: Financial Overview (2022)
  • Figure 32 Altai, Inc: Financial Overview (2022)